We are live on !
Find out more
TPG GP A Portfolio holdings
AUM
$5B
Turnover
33.68%
1-Year Est. Return
58.56%
This Fund
S&P 500
This Quarter Est. Return
+28.52%
1 Year Est. Return
+58.56%
3 Year Est. Return
+100.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$1.32B
(+36%)
Cap. Flow
+$379M
Cap. Flow % of AUM
Cap. Flow %
7.58%
Top 10 Holdings %
Top 10 Hldgs %
76.3%
Holding
95
New
19
Increased
11
Reduced
17
Closed
13
Avg Time Held
0.6
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$731M |
| 2 |
Invitation Homes
INVH
|
+$116M |
| 3 |
Odyssey Therapeutics
ODTX
|
+$64.7M |
| 4 |
Achieve Life Sciences
ACHV
|
+$32.8M |
| 5 |
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$28.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Life Time Group Holdings
LTH
|
+$315M |
| 2 |
Lifestance Health
LFST
|
+$219M |
| 3 |
Enviri
NVRI
|
+$48.9M |
| 4 |
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
|
+$30.8M |
| 5 |
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.17% |
| 2 | Industrials | 21.97% |
| 3 | Miscellaneous | 14.87% |
| 4 | Financials | 9.76% |
| 5 | Consumer Discretionary | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Lifestance Health
LFST
$4.52B
| $1.2B | 23.93% |
111,744,614
-28,281,943
| -20% | -$219M |
2021 Q4
18 quarters
|
|
|
2
SpaceX
SPCX
$1.97T
| $735M | 14.69% |
+4,300,035
| New | +$731M |
2026 Q2
0 quarters
|
|
3
Jackson Financial
JXN
$8.82B
| $483M | 9.65% |
4,715,554
| – | – |
2026 Q1
1 quarter
|
|
|
4
Life Time Group Holdings
LTH
$9B
| $322M | 6.45% |
7,894,910
-9,935,742
| -56% | -$315M |
2021 Q4
18 quarters
|
|
5
Sionna Therapeutics
SION
$179M
| $286M | 5.71% |
6,494,962
| – | – |
2025 Q1
5 quarters
|
|
6
Beta Technologies Inc
BETA
$4.25B
| $275M | 5.49% |
16,395,435
| – | – |
2025 Q4
2 quarters
|
|
7
Amneal Pharmaceuticals
AMRX
$6.66B
| $213M | 4.27% |
12,328,767
| – | – |
2021 Q4
18 quarters
|
|
|
8
Invitation Homes
INVH
$15.9B
| $124M | 2.48% |
+4,113,763
| New | +$116M |
2026 Q2
0 quarters
|
|
9
NGL Energy Partners
NGL
$1.91B
| $92.1M | 1.84% |
5,784,322
-150,171
| -3% | -$2.33M |
2026 Q1
1 quarter
|
|
10
Bicara Therapeutics
BCAX
$1.16B
| $89.4M | 1.79% |
3,010,425
| – | – |
2024 Q3
7 quarters
|
|
11
Bruker Corporation 6.375% Series A Preferred Stock
BRKRP
$1.12B
| $78.3M | 1.56% |
175,500
+12,500
| +8% | +$4.51M |
2026 Q1
1 quarter
|
|
12
CeriBell Inc
CBLL
$967M
| $73.2M | 1.46% |
3,761,154
-206,268
| -5% | -$3.92M |
2024 Q4
6 quarters
|
|
|
13
Odyssey Therapeutics
ODTX
$839M
| $69M | 1.38% |
+3,690,146
| New | +$64.7M |
2026 Q2
0 quarters
|
|
|
14
Achieve Life Sciences
ACHV
$689M
| $44.9M | 0.9% |
+6,877,580
| New | +$32.8M |
2026 Q2
0 quarters
|
|
15
Novanta Inc Units
NOVTU
$615M
| $41.7M | 0.83% |
611,667
-50,000
| -8% | -$3.13M |
2026 Q1
1 quarter
|
|
16
NextEra Energy Inc 7.375% Corporate Units
NEE.PRV
| $39.3M | 0.79% |
825,000
+250,000
| +43% | +$12.3M |
2026 Q1
1 quarter
|
|
17
Allogene Therapeutics
ALLO
$453M
| $38.9M | 0.78% |
18,716,306
| – | – |
2021 Q4
18 quarters
|
|
18
Quanex
NX
$879M
| $38.3M | 0.76% |
2,054,770
| – | – |
2026 Q1
1 quarter
|
|
|
19
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$4.32B
| $29.2M | 0.58% |
250,000
-325,000
| -57% | -$30.8M |
2026 Q1
1 quarter
|
|
20
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.08B
| $28.2M | 0.56% |
680,000
| – | – |
2026 Q1
1 quarter
|
|
|
21
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$6.85B
| $27.1M | 0.54% |
+400,000
| New | +$28.2M |
2026 Q2
0 quarters
|
|
|
22
Enviri
NVRI
$553M
| $25.6M | 0.51% |
1,164,560
-2,449,128
| -68% | -$48.9M |
2026 Q1
1 quarter
|
|
23
Avalyn Pharma
AVLN
$1.08B
| $25.4M | 0.51% |
+773,069
| New | +$22.3M |
2026 Q2
0 quarters
|
|
24
PPL Corp Corporate Units
PPLC
| $20.5M | 0.41% |
420,000
+50,000
| +14% | +$2.48M |
2026 Q1
1 quarter
|
|
25
TPG RE Finance Trust
TRTX
$437M
| $20M | 0.4% |
2,392,863
| – | – |
2021 Q4
18 quarters
|
|
Similar funds
SFM
TPG GP A's Q2 2026 Portfolio in Review
As of Q2 2026, TPG GP A held 95 positions worth $5B, up 36% from $3.68B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
TPG GP A deployed $379M of net new capital in Q2 2026, opening 19 new positions and adding to 11 existing holdings. Its largest new stake was SpaceX: 4,300,035 shares worth $735M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 41% a quarter earlier, followed by Industrials and Miscellaneous.
On the sell side, the largest reduction was Life Time Group Holdings, an estimated $315M trimmed.
- TPG GP A's largest Q2 2026 buy was SpaceX: 4,300,035 shares worth $735M.
- TPG GP A added most to NextEra Energy Inc 7.375% Corporate Units in Q2 2026, an estimated $12.3M increase.
- TPG GP A's biggest Q2 2026 reduction was Life Time Group Holdings, cutting an estimated $315M.
- TPG GP A fully exited Oracle Corp Preferred Stock Series D in Q2 2026, selling an estimated $10.3M.
- TPG GP A's ten largest holdings make up 76% of its $5B portfolio in Q2 2026.
- TPG GP A opened 19 new positions and closed 13 in Q2 2026.
- TPG GP A's portfolio value rose 36% quarter-over-quarter to $5B.
Based on TPG GP A's 13F filing for Q2 2026, filed 14 Aug 2026.